Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 29

1.

Acute-Onset Pneumonitis while Administering the First Dose of Durvalumab.

Tonk EHJ, van Lindert ASR, Verhoeff JJC, Suijkerbuijk KPM.

Case Rep Oncol. 2019 Aug 6;12(2):621-624. doi: 10.1159/000502202. eCollection 2019 May-Aug.

2.

Brain and Head-and-Neck MRI in Immobilization Mask: A Practical Solution for MR-Only Radiotherapy.

Mandija S, D'Agata F, Navest RJM, Sbrizzi A, Tijssen RHN, Philippens MEP, Raaijmakers CPJ, Seravalli E, Verhoeff JJC, Lagendijk JJW, van den Berg CAT.

Front Oncol. 2019 Jul 17;9:647. doi: 10.3389/fonc.2019.00647. eCollection 2019.

3.

Radiotherapy Late Effects and Osteogenesis Imperfecta: Dos and Don'ts in Clinical Practice.

Lodeweges JE, van Dijk FS, Verhoeff JJC.

Case Rep Oncol. 2019 Apr 17;12(1):322-331. doi: 10.1159/000499903. eCollection 2019 Jan-Apr.

4.

Prognostic Value of Brain Metastasis-Free Interval in Patients with Breast Cancer Brain Metastases.

Hulsbergen AFC, Lamba N, Claes A, Kavouridis VK, Lin NU, Smith TR, Verhoeff JJC, Broekman MLD.

World Neurosurg. 2019 Apr 26. pii: S1878-8750(19)31064-2. doi: 10.1016/j.wneu.2019.04.072. [Epub ahead of print]

PMID:
31035019
5.

Changes in cortical thickness and volume after cranial radiation treatment: A systematic review.

Nagtegaal SHJ, David S, van der Boog ATJ, Leemans A, Verhoeff JJC.

Radiother Oncol. 2019 Jun;135:33-42. doi: 10.1016/j.radonc.2019.02.013. Epub 2019 Mar 6. Review.

PMID:
31015168
6.

A Systematic Review of Devices and Techniques that Objectively Measure Patients' Pain.

Wagemakers SH, van der Velden JM, Gerlich AS, Hindriks-Keegstra AW, van Dijk JFM, Verhoeff JJC.

Pain Physician. 2019 Jan;22(1):1-13.

7.

Patterns of re-irradiation for recurrent gliomas and validation of a prognostic score.

Post CCB, Kramer MCA, Smid EJ, van der Weide HL, Kleynen CE, Heesters MAAM, Verhoeff JJC.

Radiother Oncol. 2019 Jan;130:156-163. doi: 10.1016/j.radonc.2018.10.034. Epub 2018 Nov 13.

PMID:
30446315
8.

MR-Only Brain Radiation Therapy: Dosimetric Evaluation of Synthetic CTs Generated by a Dilated Convolutional Neural Network.

Dinkla AM, Wolterink JM, Maspero M, Savenije MHF, Verhoeff JJC, Seravalli E, Išgum I, Seevinck PR, van den Berg CAT.

Int J Radiat Oncol Biol Phys. 2018 Nov 15;102(4):801-812. doi: 10.1016/j.ijrobp.2018.05.058. Epub 2018 Jun 4.

PMID:
30108005
9.

Survival after whole brain radiotherapy for brain metastases from lung cancer and breast cancer is poor in 6325 Dutch patients treated between 2000 and 2014.

Jeene PM, de Vries KC, van Nes JGH, Kwakman JJM, Wester G, Rozema T, Braam PM, Zindler JD, Koper P, Nuyttens JJ, Vos-Westerman HA, Schmeets I, Niël CGHJ, Hutschemaekers S, van der Linden YM, Verhoeff JJC, Stalpers LJA.

Acta Oncol. 2018 May;57(5):637-643. doi: 10.1080/0284186X.2017.1418534. Epub 2017 Dec 23.

PMID:
29276848
10.

Ischemic stroke after radiation therapy for pituitary adenomas: a systematic review.

van Westrhenen A, Muskens IS, Verhoeff JJC, Smith TRS, Broekman MLD.

J Neurooncol. 2017 Oct;135(1):1-11. doi: 10.1007/s11060-017-2530-9. Epub 2017 Jun 28. Review.

11.

Stereotactic radiosurgery versus whole-brain radiotherapy after intracranial metastasis resection: a systematic review and meta-analysis.

Lamba N, Muskens IS, DiRisio AC, Meijer L, Briceno V, Edrees H, Aslam B, Minhas S, Verhoeff JJC, Kleynen CE, Smith TR, Mekary RA, Broekman ML.

Radiat Oncol. 2017 Jun 24;12(1):106. doi: 10.1186/s13014-017-0840-x. Review.

12.

In vivo phage display screening for tumor vascular targets in glioblastoma identifies a llama nanobody against dynactin-1-p150Glued.

van Lith SA, Roodink I, Verhoeff JJ, Mäkinen PI, Lappalainen JP, Ylä-Herttuala S, Raats J, van Wijk E, Roepman R, Letteboer SJ, Verrijp K, Leenders WP.

Oncotarget. 2016 Nov 1;7(44):71594-71607. doi: 10.18632/oncotarget.12261.

13.

A 43-Year-Old Female with Multifocal Cerebral Lesions. Histiocytic Sarcoma.

Nieuwenhuis MB, van der Salm SM, Verhoeff JJ, van der Kooi AJ, Slavujecvic-Letic I, Pals ST, Vos JM.

Brain Pathol. 2015 May;25(3):371-2. No abstract available.

PMID:
26086057
14.

Bevacizumab in combination with radiotherapy and temozolomide for patients with newly diagnosed glioblastoma multiforme.

van Linde ME, Verhoeff JJ, Richel DJ, van Furth WR, Reijneveld JC, Verheul HM, Stalpers LJ.

Oncologist. 2015 Feb;20(2):107-8. doi: 10.1634/theoncologist.2014-0418. Epub 2015 Jan 12.

15.

Therapy-resistant tumor microvascular endothelial cells contribute to treatment failure in glioblastoma multiforme.

Borovski T, Beke P, van Tellingen O, Rodermond HM, Verhoeff JJ, Lascano V, Daalhuisen JB, Medema JP, Sprick MR.

Oncogene. 2013 Mar 21;32(12):1539-48. doi: 10.1038/onc.2012.172. Epub 2012 May 21.

PMID:
22614016
16.

Model-based, semiquantitative and time intensity curve shape analysis of dynamic contrast-enhanced MRI: a comparison in patients undergoing antiangiogenic treatment for recurrent glioma.

Lavini C, Verhoeff JJ, Majoie CB, Stalpers LJ, Richel DJ, Maas M.

J Magn Reson Imaging. 2011 Dec;34(6):1303-12. doi: 10.1002/jmri.22742. Epub 2011 Sep 23.

PMID:
21954019
17.

Expression of the progenitor marker NG2/CSPG4 predicts poor survival and resistance to ionising radiation in glioblastoma.

Svendsen A, Verhoeff JJ, Immervoll H, Brøgger JC, Kmiecik J, Poli A, Netland IA, Prestegarden L, Planagumà J, Torsvik A, Kjersem AB, Sakariassen PØ, Heggdal JI, Van Furth WR, Bjerkvig R, Lund-Johansen M, Enger PØ, Felsberg J, Brons NH, Tronstad KJ, Waha A, Chekenya M.

Acta Neuropathol. 2011 Oct;122(4):495-510. doi: 10.1007/s00401-011-0867-2. Epub 2011 Aug 24.

18.
19.

Bevacizumab and dose-intense temozolomide in recurrent high-grade glioma.

Verhoeff JJ, Lavini C, van Linde ME, Stalpers LJ, Majoie CB, Reijneveld JC, van Furth WR, Richel DJ.

Ann Oncol. 2010 Aug;21(8):1723-7. doi: 10.1093/annonc/mdp591. Epub 2010 Jan 11.

PMID:
20064829
20.

Cancer stem cell tumor model reveals invasive morphology and increased phenotypical heterogeneity.

Sottoriva A, Verhoeff JJ, Borovski T, McWeeney SK, Naumov L, Medema JP, Sloot PM, Vermeulen L.

Cancer Res. 2010 Jan 1;70(1):46-56. doi: 10.1158/0008-5472.CAN-09-3663.

21.

Concerns about anti-angiogenic treatment in patients with glioblastoma multiforme.

Verhoeff JJ, van Tellingen O, Claes A, Stalpers LJ, van Linde ME, Richel DJ, Leenders WP, van Furth WR.

BMC Cancer. 2009 Dec 16;9:444. doi: 10.1186/1471-2407-9-444. Review.

22.

Tumour control by whole brain irradiation of anti-VEGF-treated mice bearing intracerebral glioma.

Verhoeff JJ, Stalpers LJ, Claes A, Hovinga KE, Musters GD, Peter Vandertop W, Richel DJ, Leenders WP, van Furth WR.

Eur J Cancer. 2009 Nov;45(17):3074-80. doi: 10.1016/j.ejca.2009.08.004. Epub 2009 Sep 4.

PMID:
19734041
23.

Angiogenesis inhibitor DC101 delays growth of intracerebral glioblastoma but induces morbidity when combined with irradiation.

Verhoeff JJ, Stalpers LJ, Van Noorden CJ, Troost D, Ramkema MD, van Bree C, Song JY, Donker M, Chekenya M, Vandertop WP, Richel DJ, van Furth WR.

Cancer Lett. 2009 Nov 18;285(1):39-45. doi: 10.1016/j.canlet.2009.04.038. Epub 2009 May 26.

PMID:
19473756
24.

Tumor microvasculature supports proliferation and expansion of glioma-propagating cells.

Borovski T, Verhoeff JJ, ten Cate R, Cameron K, de Vries NA, van Tellingen O, Richel DJ, van Furth WR, Medema JP, Sprick MR.

Int J Cancer. 2009 Sep 1;125(5):1222-30. doi: 10.1002/ijc.24408.

25.

[Cancer stem cells].

Vermeulen L, Verhoeff JJ, Richel DJ, Medema JP.

Ned Tijdschr Geneeskd. 2009 Feb 14;153(7):286-90. Review. Dutch. No abstract available.

PMID:
19291944
26.

Bowel perforation after radiotherapy in a patient receiving sorafenib.

Peters NA, Richel DJ, Verhoeff JJ, Stalpers LJ.

J Clin Oncol. 2008 May 10;26(14):2405-6. doi: 10.1200/JCO.2007.15.8451. No abstract available.

PMID:
18467733
27.

Experimental iodine-125 seed irradiation of intracerebral brain tumors in nude mice.

Verhoeff JJ, Stalpers LJ, Coumou AW, Koedooder K, Lavini C, Van Noorden CJ, Haveman J, Vandertop WP, van Furth WR.

Radiat Oncol. 2007 Sep 26;2:38.

28.

Negligible radiation protection of endothelial cells by vascular endothelial growth factor.

Donker M, Van Furth WR, Mulder-Van Der Kracht S, Hovinga KE, Verhoeff JJ, Stalpers LJ, van Bree C.

Oncol Rep. 2007 Sep;18(3):709-14.

PMID:
17671724
29.

Radiation-enhanced vascular endothelial growth factor (VEGF) secretion in glioblastoma multiforme cell lines--a clue to radioresistance?

Hovinga KE, Stalpers LJ, van Bree C, Donker M, Verhoeff JJ, Rodermond HM, Bosch DA, van Furth WR.

J Neurooncol. 2005 Sep;74(2):99-103.

PMID:
16193379

Supplemental Content

Loading ...
Support Center